{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:41Z","timestamp":1792791581734,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.josat.2026.210139","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:08:41Z","timestamp":1792163321000},"page":"210139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["States rely heavily on temporary federal funds to address opioid addiction in the criminal legal population"],"prefix":"10.1016","volume":"192","author":[{"given":"Miguel Antonio G.","family":"Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2026.210139_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/appi.ps.201700196","article-title":"State-targeted funding and technical assistance to increase access to medication treatment for opioid use disorder","volume":"69","author":"Abraham","year":"2018","journal-title":"Psychiatric Services"},{"issue":"6","key":"10.1016\/j.josat.2026.210139_bb0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2105\/AJPH.2019.305052","article-title":"Changes in state technical assistance priorities and block grant funds for addiction after ACA implementation","volume":"109","author":"Abraham","year":"2019","journal-title":"American Journal of Public Health"},{"issue":"7","key":"10.1016\/j.josat.2026.210139_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1377\/hlthaff.2022.01568","article-title":"State funding for substance use disorder treatment declined in the wake of Medicaid expansion","volume":"42","author":"Andrews","year":"2023","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.josat.2026.210139_bb0020","author":"Baumrucker"},{"issue":"1","key":"10.1016\/j.josat.2026.210139_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40352-025-00317-9","article-title":"Medication for opioid use disorder service delivery in carceral facilities: Update and summary report","volume":"13","author":"Berk","year":"2025","journal-title":"Health Justice."},{"issue":"3","key":"10.1016\/j.josat.2026.210139_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2732","article-title":"Prison buprenorphine implementation and postrelease opioid use disorder outcomes","volume":"7","author":"Bovell-Ammon","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210139_bb0035","series-title":"Correctional populations in the United States, 2022 \u2013 Statistical tables","author":"Buehler","year":"2024"},{"key":"10.1016\/j.josat.2026.210139_bb0040","series-title":"State and federal prisoners, 2016 - Drug use disorder","author":"Bureau of Justice Statistics","year":"2016"},{"key":"10.1016\/j.josat.2026.210139_bb0045","series-title":"Mortality in state and federal prisons, 2001\u20132019, statistical tables","author":"Carson","year":"2021"},{"key":"10.1016\/j.josat.2026.210139_bb0050","series-title":"Mortality in local jails, 2000\u20132019, statistical tables","author":"Carson","year":"2021"},{"key":"10.1016\/j.josat.2026.210139_bb0055","series-title":"Results from the 2016 National Survey on Drug Use and Health: Detailed tables","author":"Center for Behavioral Health Statistics and Quality","year":"2017"},{"key":"10.1016\/j.josat.2026.210139_bb0060","author":"Congressional Research Service"},{"key":"10.1016\/j.josat.2026.210139_bb0065","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2026.210139_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209309","article-title":"Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies","volume":"160","author":"Estrada","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210139_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109254","article-title":"Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder","volume":"231","author":"Evans","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210139_bb0080","author":"Frank"},{"issue":"10","key":"10.1016\/j.josat.2026.210139_bb0085","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMsa2415987","article-title":"Medications for opioid use disorder in county jails \u2014 Outcomes after release","volume":"393","author":"Friedmann","year":"2025","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.210139_bb0090","author":"General Accountability Office"},{"issue":"4","key":"10.1016\/j.josat.2026.210139_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.josat.2026.210139_bb0100","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1377\/hlthaff.2016.0623","article-title":"Survey highlights differences in Medicaid coverage for substance use treatment and opioid use disorder medications","volume":"35","author":"Grogan","year":"2016","journal-title":"Health Aff (Millwood)."},{"issue":"S1","key":"10.1016\/j.josat.2026.210139_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/1468-0009.70048","article-title":"The largest program for opioid use disorder in a statewide carceral system: A collaborative multi-agency initiative","volume":"103","author":"Jordan","year":"2025","journal-title":"The Milbank Quarterly"},{"key":"10.1016\/j.josat.2026.210139_bb0110","author":"Kaiser Family Foundation"},{"key":"10.1016\/j.josat.2026.210139_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209103","article-title":"The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose","volume":"152","author":"Klemperer","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"3","key":"10.1016\/j.josat.2026.210139_bb0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/add.16071","article-title":"Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011\u201317","volume":"118","author":"Lim","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210139_bb0125","series-title":"Work and opportunity before and after incarceration","author":"Looney","year":"2018"},{"key":"10.1016\/j.josat.2026.210139_bb0130","series-title":"Parents in prison and their minor children","author":"Maruschak","year":"2021"},{"key":"10.1016\/j.josat.2026.210139_bb0135","series-title":"Opioid use disorder screening and treatment in local jails, 2019","author":"Maruschak","year":"2023"},{"key":"10.1016\/j.josat.2026.210139_bb0140","series-title":"Report to Congress on Medicaid and CHIP","article-title":"Access to Medicaid coverage and care for adults leaving incarceration","author":"Medicaid and CHIP Payment and Access Commission","year":"2023"},{"key":"10.1016\/j.josat.2026.210139_bb0150","series-title":"Fiscal year 2024 appropriations","author":"National Association of State Alcohol and Drug Abuse Directors","year":"2024"},{"key":"10.1016\/j.josat.2026.210139_bb0155","series-title":"States' use of grant funding for a targeted response to the opioid crisis","author":"Office of Inspector General","year":"2020"},{"key":"10.1016\/j.josat.2026.210139_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209248","article-title":"Expanding access to medication for opioid use disorder (MOUD) in jails: A comprehensive program evaluation","volume":"161","author":"Pourtaher","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"9","key":"10.1016\/j.josat.2026.210139_bb0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.josat.2026.210139_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1377\/hlthaff.2019.01428","article-title":"Specialty substance use disorder treatment admissions steadily increased in the four years after Medicaid expansion","volume":"39","author":"Saloner","year":"2020","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.josat.2026.210139_bb0180","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"6","key":"10.1016\/j.josat.2026.210139_bb0185","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","article-title":"Availability of medications for opioid use disorder in U.S. jails","volume":"38","author":"Sufrin","year":"2023","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2026.210139_bb0190","author":"U.S. Department of Justice"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:59:51Z","timestamp":1792789191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":36,"alternative-id":["S2949875926002596"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210139","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"States rely heavily on temporary federal funds to address opioid addiction in the criminal legal population","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210139"}}